Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Japan Medical Dynamic MarketingJMDMF 79 Earnings Yield (Joel Greenblatt) % is 4.10% as of Mar. 2026, which is 34% below its 10-year median of 6.23. GuruFocus rates JMDMF with a GF Score™ of 79/100 and a GF Value™ of $3.60. The stock has 10 warning signs investors should review. Among 849 Medical Devices & Instruments companies, Japan Medical Dynamic Marketing ranks worse than 53.12% on this metric.
Japan Medical Dynamic Marketing's Enterprise Value for the quarter that ended in Mar. 2026 was $96.9 Mil.
Japan Medical Dynamic Marketing's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was $0.5 Mil. Japan Medical Dynamic Marketing's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2026 was 4.10%.
The historical rank and industry rank for Japan Medical Dynamic Marketing's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
JMDMF'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -5.58 Med: 6.23 Max: 11.51
Current: 0.23
During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of Japan Medical Dynamic Marketing was 11.51%. The lowest was -5.58%. And the median was 6.23%.
JMDMF's Earnings Yield (Joel Greenblatt) % is ranked worse than 53.12% of 849
companies
in the Medical Devices & Instruments industry
Industry Median: 0.83
vs JMDMF: 0.23
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Japan Medical Dynamic Marketing's Forward Rate of Return (Yacktman) % for the quarter that ended in Mar. 2026 was -12.33%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Japan Medical Dynamic Marketing (OTCPK:JMDMF) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Japan Medical Dynamic Marketing Earnings Yield (Joel Greenblatt) % Chart
For the Medical Devices subindustry, Japan Medical Dynamic Marketing's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Japan Medical Dynamic Marketing Earnings Yield (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Japan Medical Dynamic Marketing's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Japan Medical Dynamic Marketing's Earnings Yield (Joel Greenblatt) % falls into.
Japan Medical Dynamic Marketing Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Japan Medical Dynamic Marketings Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Mar. 2026 is calculated as
Japan Medical Dynamic Marketing's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.5 Mil.
What does a Earnings Yield (Joel Greenblatt) % of 4.10% mean?
Japan Medical Dynamic Marketing (JMDMF) has a Earnings Yield (Joel Greenblatt) % of 4.10% as of Mar. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Japan Medical Dynamic Marketing and its competitors. This is 34% below median its historical median of 6.23. According to the industry distribution chart, Japan Medical Dynamic Marketing ranks #451 out of 849 companies in the Medical Devices & Instruments industry, placing it in the top 53.1%.
Is Japan Medical Dynamic Marketing's Earnings Yield (Joel Greenblatt) % too high?
Japan Medical Dynamic Marketing's current Earnings Yield (Joel Greenblatt) % of 4.10% is 34% below median its 10-year median of 6.23. The Medical Devices & Instruments industry median Earnings Yield (Joel Greenblatt) % is 0.83. Japan Medical Dynamic Marketing's value of 4.10% is 394% above this industry median. Based on the distribution chart, Japan Medical Dynamic Marketing ranks #451 out of 849 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Japan Medical Dynamic Marketing has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does Japan Medical Dynamic Marketing's Earnings Yield (Joel Greenblatt) % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Japan Medical Dynamic Marketing ranks #451 out of 849 companies for Earnings Yield (Joel Greenblatt) %. This places Japan Medical Dynamic Marketing in the lower half of its industry. The industry median Earnings Yield (Joel Greenblatt) % is 0.83. Japan Medical Dynamic Marketing's value of 4.10% is 394% above this benchmark. While the company's 10-year median is 6.23 vs. the industry median of 0.83, Japan Medical Dynamic Marketing has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median Earnings Yield (Joel Greenblatt) % among Medical Devices & Instruments companies is 0.83, based on 849 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Japan Medical Dynamic Marketing's current Earnings Yield (Joel Greenblatt) % of 4.10% is 394% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Japan Medical Dynamic Marketing and its competitors. For the Medical Devices & Instruments industry, the median Earnings Yield (Joel Greenblatt) % is 0.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Japan Medical Dynamic Marketing's current Earnings Yield (Joel Greenblatt) % is 4.10%, which is 34% below median its own 10-year median of 6.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Japan Medical Dynamic Marketing stock overvalued right now?
Japan Medical Dynamic Marketing (JMDMF) has a current Earnings Yield (Joel Greenblatt) % of 4.10%. The stock's GF Value™ is $3.60, compared to a current price of $5.00 — trading 38.9% above its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is 4.10%, which is 34% below median its 10-year median of 6.23 and 394% above the Medical Devices & Instruments industry median of 0.83. Japan Medical Dynamic Marketing's overall GF Score™ is 79/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For Japan Medical Dynamic Marketing (JMDMF), the current Earnings Yield (Joel Greenblatt) % is 4.10% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Japan Medical Dynamic Marketing (JMDMF) Overvalued in 2026?
Based on GuruFocus' analysis, Japan Medical Dynamic Marketing stock appears to be overvalued.
The current stock price of $5.00 is trading 38.9% above its estimated GF Value™ of $3.60.
Key valuation signals for JMDMF:
Earnings Yield (Joel Greenblatt) %: 4.10% (34% below median its 10-year median of 6.23)
GF Value™: $3.60 vs. price of $5.00 (38.9% above fair value)
Industry Position: 394% above the Medical Devices & Instruments median (#451 of 849)
No single metric tells the full story. See the JMDMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Japan Medical Dynamic Marketing Inc is a Japan-based medical equipment manufacturer. The company is engaged in the development and sale of advanced medical devices. Products offered by the company include trauma devices, joint prostheses, spinal fixation devices, and artificial bone fillers. It caters its products to medical professionals and major hospitals throughout Japan. The company is also engaged in the import and sale of medical devices.
79GF Score
Get the complete analysis for JMDMF
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JMDMF has been successfully added to your 
